Five Prime Therapeutics, Inc. FPRX
— —
Day range unavailable
52-week range unavailable
FPRX revenue history
Revenue is income from the company’s ordinary business activities.
13,178,000 USD
FY 2020 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2020 | 2020-12-31 | 13,178,000 | -1,696,000 | -11.40% |
| FY 2019 | 2019-12-31 | 14,874,000 | -34,994,000 | -70.17% |
| FY 2018 | 2018-12-31 | 49,868,000 | 10,360,000 | 26.22% |
| FY 2017 | 2017-12-31 | 39,508,000 | 8,817,000 | 28.73% |
| FY 2016 | 2016-12-31 | 30,691,000 | -349,110,000 | -91.92% |
| FY 2015 | 2015-12-31 | 379,801,000 | 360,570,000 | 1874.94% |
| FY 2014 | 2014-12-31 | 19,231,000 | 5,440,000 | 39.45% |
| FY 2013 | 2013-12-31 | 13,791,000 | 3,808,000 | 38.14% |
| FY 2012 | 2012-12-31 | 9,983,000 | -54,933,000 | -84.62% |
| FY 2011 | 2011-12-31 | 64,916,000 | 64,916,000 | Not meaningful |
| FY 2010 | 2010-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:02:52.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.